Refractory Aggressive Non-Hodgkin's Lymphoma
1 clinical trials · Condition
◉ Watch Refractory Aggressive Non-Hodgkin's Lymphoma
| Record | Firm | Date |
|---|---|---|
| Phase II Evaluation of Gemcitabine- Rituximab-Oxaliplatin Combination (GROC) in Relapsed Aggressive Lymphomas (NCT01538641) | Auxilio Mutuo Cancer Center | 2003-10-01 |
Track Refractory Aggressive Non-Hodgkin's Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.